Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.
Year: 1997
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: S Senan, R Rampling, M A Graham, P Wilson, H Robin, N Eckardt, N Lawson, A McDonald, R von Roemeling, P Workman, S B Kaye
Institution: University of Glasgow
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1684733013
